DE69837565D1 - Mutationen des menschlichen mink gens, die mit arrhytmie verbunden sind - Google Patents

Mutationen des menschlichen mink gens, die mit arrhytmie verbunden sind

Info

Publication number
DE69837565D1
DE69837565D1 DE69837565T DE69837565T DE69837565D1 DE 69837565 D1 DE69837565 D1 DE 69837565D1 DE 69837565 T DE69837565 T DE 69837565T DE 69837565 T DE69837565 T DE 69837565T DE 69837565 D1 DE69837565 D1 DE 69837565D1
Authority
DE
Germany
Prior art keywords
mutations
syndrome
long
disclosed
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69837565T
Other languages
English (en)
Other versions
DE69837565T2 (de
Inventor
Mark T Keating
Michael C Sanguinetti
Igor Splawski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
Original Assignee
University of Utah Research Foundation UURF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26788932&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69837565(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Utah Research Foundation UURF filed Critical University of Utah Research Foundation UURF
Publication of DE69837565D1 publication Critical patent/DE69837565D1/de
Application granted granted Critical
Publication of DE69837565T2 publication Critical patent/DE69837565T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69837565T 1998-07-29 1998-10-06 Mutationen des menschlichen mink gens, die mit arrhytmie verbunden sind Expired - Lifetime DE69837565T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9447798P 1998-07-29 1998-07-29
US94477P 1998-07-29
US135020 1998-08-17
US09/135,020 US6274332B1 (en) 1995-12-22 1998-08-17 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
PCT/US1998/017838 WO2000006600A1 (en) 1998-07-29 1998-10-06 Human mink gene mutations associated with arrhythmia

Publications (2)

Publication Number Publication Date
DE69837565D1 true DE69837565D1 (de) 2007-05-24
DE69837565T2 DE69837565T2 (de) 2007-12-27

Family

ID=26788932

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837565T Expired - Lifetime DE69837565T2 (de) 1998-07-29 1998-10-06 Mutationen des menschlichen mink gens, die mit arrhytmie verbunden sind

Country Status (8)

Country Link
US (6) US6274332B1 (de)
EP (1) EP1100825B1 (de)
JP (1) JP2003530814A (de)
KR (1) KR20010085315A (de)
AT (1) ATE359299T1 (de)
CA (1) CA2337491C (de)
DE (1) DE69837565T2 (de)
WO (1) WO2000006600A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274332B1 (en) * 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
US6458542B1 (en) * 1999-10-08 2002-10-01 Vanderbilt University Method of screening for susceptibility to drug-induced cardiac arrhythmia
US7115726B2 (en) * 2001-03-30 2006-10-03 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
AU2002258922A1 (en) * 2001-04-24 2002-11-05 University Of Utah Research Foundation Method for assessing risk for cardiac dysrhythmia in a human subject
US20030073085A1 (en) * 2001-10-05 2003-04-17 Fang Lai Amplifying expressed sequences from genomic DNA of higher-order eukaryotic organisms for DNA arrays
US20040053232A1 (en) * 2001-10-05 2004-03-18 Perlegen Sciences, Inc. Haplotype structures of chromosome 21
US8013133B2 (en) 2003-04-25 2011-09-06 Medtronic, Inc. Genetic modification of targeted regions of the cardiac conduction system
US7537928B2 (en) * 2003-08-22 2009-05-26 Masonic Medical Research Laboratory Mutations in ion channel proteins associated with sudden cardiac death
WO2005078452A1 (en) * 2004-02-05 2005-08-25 Medtronic, Inc. Methods and apparatus for identifying patients at risk for life threatening arrhythmias
US7608458B2 (en) * 2004-02-05 2009-10-27 Medtronic, Inc. Identifying patients at risk for life threatening arrhythmias
US7127355B2 (en) 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
US20090087854A1 (en) * 2007-09-27 2009-04-02 Perlegen Sciences, Inc. Methods for genetic analysis
US8335652B2 (en) * 2004-06-23 2012-12-18 Yougene Corp. Self-improving identification method
US8027791B2 (en) * 2004-06-23 2011-09-27 Medtronic, Inc. Self-improving classification system
US20050287574A1 (en) * 2004-06-23 2005-12-29 Medtronic, Inc. Genetic diagnostic method for SCD risk stratification
US7833718B2 (en) * 2006-11-06 2010-11-16 Masonic Medical Research Laboratory CACNA1C nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death
EP2229588A4 (de) * 2007-11-14 2011-05-25 Medtronic Inc Diagnostische kits und verfahren für die scd- oder sca-therapieauswahl
US20110143956A1 (en) * 2007-11-14 2011-06-16 Medtronic, Inc. Diagnostic Kits and Methods for SCD or SCA Therapy Selection
EP2430184A2 (de) * 2009-05-12 2012-03-21 Medtronic, Inc. Sca-risikostratifizierung durch vorhersage des ansprechens von patienten auf antiarrhythmika

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397702A (en) * 1989-03-06 1995-03-14 The Regents Of The University Of California Assay for and treatment of autoimmune diseases
US5387702A (en) * 1993-09-29 1995-02-07 Council Of Scientific And Industrial Research Process for the preparation of cabofuran
ES2325820T3 (es) * 1995-12-22 2009-09-18 University Of Utah Research Foundation Gen del sindrome qt largo que codifica kvlqt1 y su asociacion con mink.
US6274332B1 (en) * 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
US6150104A (en) * 1997-06-13 2000-11-21 University Of Utah Research Foundation Homozygous mutation in KVLQT1 which causes Jervell and Lange Nielsen syndrome
US6207383B1 (en) * 1998-07-27 2001-03-27 University Of Utah Research Foundation Mutations in and genomic structure of HERG—a long QT syndrome gene

Also Published As

Publication number Publication date
WO2000006600A1 (en) 2000-02-10
US20040235038A1 (en) 2004-11-25
KR20010085315A (ko) 2001-09-07
CA2337491A1 (en) 2000-02-10
EP1100825A4 (de) 2003-06-11
ATE359299T1 (de) 2007-05-15
CA2337491C (en) 2010-06-22
US7247436B2 (en) 2007-07-24
EP1100825B1 (de) 2007-04-11
US6274332B1 (en) 2001-08-14
US6323026B1 (en) 2001-11-27
US6432644B1 (en) 2002-08-13
JP2003530814A (ja) 2003-10-21
US20050003439A1 (en) 2005-01-06
EP1100825A1 (de) 2001-05-23
DE69837565T2 (de) 2007-12-27
US20030054380A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
DE69837565D1 (de) Mutationen des menschlichen mink gens, die mit arrhytmie verbunden sind
Cossée et al. Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations
Nagl et al. Persistence of neutral polymorphisms in Lake Victoria cichlid fish
Olschwang et al. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene.
Doyle et al. Origins, colonization, and lineage recombination in a widespread perennial soybean polyploid complex
Lucas et al. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation
FR2731014B1 (fr) Molecules d'adn, preparation et utilisation en therapie genique
Gad et al. Identification of a large rearrangement of theBRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
ATE464391T1 (de) Hyaluronidase aus menschlichem plasma
CY1111662T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΝΟΜΕΝΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
ATE546546T1 (de) Genanalysesysteme und -verfahren
PT973794E (pt) Receptores de netrina
Ueda et al. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan
EP1100538A4 (de) Kvlqt1 - im zusammenhang mit 'long qt syndrom'
Onodera et al. High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan
ATE371022T1 (de) Fy7 polymerase
Okamura et al. Whole-exome sequencing of fibroblast and its iPS cell lines derived from a patient diagnosed with xeroderma pigmentosum
WO2001049118A8 (en) Compositions comprising genome segments and methods of using the same
DE60044203D1 (de) Gen das in schizophrenie defekt ist
WO1998025125A3 (en) Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus
Vega-Requena et al. Genetic admixture analysis in the population of Tacuarembó-Uruguay using Alu insertions
WO2000034476A3 (en) Nucleic acid molecules of shrimp
Neri et al. Microsatellite instability in in vitro ageing of T lymphocyte clones
Fattah et al. Y-chromosomal STR variation in Kurds and Arabs population in Iraqi Kurdistan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition